IFP Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64K Buy
167
+152
+1,013% +$1.5K ﹤0.01% 4325
2026
Q1
$146 Hold
15
﹤0.01% 4677
2025
Q4
$143 Hold
15
﹤0.01% 4537
2025
Q3
$146 Buy
+15
New +$115 ﹤0.01% 4461
2025
Q2
Sell
-132
Closed -$991 3303
2025
Q1
$1.63K Hold
132
﹤0.01% 3210
2024
Q4
$1.83K Buy
+132
New +$2.08K ﹤0.01% 3134
2021
Q3
Sell
-20
Closed -$1K 3437
2021
Q2
$1K Buy
20
+1
+5% +$31 ﹤0.01% 2929
2021
Q1
$0 Buy
19
+2
+12% +$38 ﹤0.01% 3176
2020
Q4
$0 Sell
17
-19
-53% -$225 ﹤0.01% 3061
2020
Q3
$0 Buy
+36
New +$433 ﹤0.01% 2974
2018
Q4
Sell
-1
Closed 3795
2018
Q3
$0 Hold
1
﹤0.01% 3980
2018
Q2
$0 Hold
1
﹤0.01% 4016
2018
Q1
$0 Hold
1
﹤0.01% 3815
2017
Q4
$0 Sell
1
-4
-80% -$204 ﹤0.01% 4045
2017
Q3
$0 Hold
5
﹤0.01% 4172
2017
Q2
$0 Buy
5
+1
+25% +$53 ﹤0.01% 4178
2017
Q1
$0 Hold
4
﹤0.01% 4098
2016
Q4
$0 Hold
4
﹤0.01% 4097
2016
Q3
$0 Hold
4
﹤0.01% 4004
2016
Q2
$0 Buy
+4
New +$174 ﹤0.01% 4010
2016
Q1
Sell
-16
Closed -$1K 3173
2015
Q4
$1K Buy
+16
New +$965 ﹤0.01% 3544

Other funds holding PRTA

IFP Advisors's PRTA Position: Q2 2026 in Review

IFP Advisors increased its Prothena Corp (PRTA) stake by 1,013% in Q2 2026, buying an estimated $1.5K and bringing the position to 167 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #4325.

IFP Advisors first reported a position in PRTA in Q4 2015 and has held it in 21 quarters since. The position peaked at $1.83K in Q4 2024. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • IFP Advisors held 167 shares of Prothena Corp worth $1.64K as of Q2 2026.
  • IFP Advisors bought 152 Prothena Corp shares in Q2 2026, an estimated $1.5K.
  • Prothena Corp made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4325 holding.
  • IFP Advisors first reported a position in Prothena Corp in Q4 2015 and has held it in 21 quarters since.
  • IFP Advisors's Prothena Corp position peaked at $1.83K in Q4 2024.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.